Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00550420
Show Display Options
Rank Status Study
1 Terminated Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone XR

Indicates status has not been verified in more than two years